Highlights in Hepatocellular Carcinoma

Published: 2013-05-06
We are glad to tell you that Chinese Clinical Oncology will launch a special issue on Hepatocellular Carcinoma in the third quarter of 2013, which studies HCC in different specific circumstance given due consideration. Our Guest Editor for this special issue is Dr Ghassan K. Abou-Alfa, from Memorial Sloan-Kettering Cancer Center, New York, USA.

In this special issue, known experts worldwide in related field are getting together to share their knowledge in terms of diagnosis and treatment of HCC. Apart from the up-to-date review in HCC, You will also be able to learn the status of HCC in a wide geographic background including Asia, Europe and America. We hope you will enjoy this special issue.

The outline for this special issue is as follows:

Ghassan K. Abou-Alfa 
Memorial Sloan-Kettering Cancer Center, New York, USA

Hepatitis Risk Factors
Maya Gambarin
Section of Gastroenterology, Memorial Sloan-Kettering Cancer Center, New York, USA

Scoring and staging
Alan Venook
Professor of Clinical Medicine, Division of Hematology Oncology, University of California San Francisco, San Francisco, CA, USA

Cirrhosis management
Roniel Cabrera
Department of Medicine, Section of Hepatobiliary Diseases, University of Florida, FL, USA

Surgical and Transplant interventions
IoannisKonstantinidis andYuman Fong
Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA

Local Therapies
Jeffrey Geschwind
Director of Vascular and Interventional Radiology, Interventional Radiology Center, Johns Hopkins Hospital, Baltimore, MD, USA

Systemic therapy for HCC
James Harding and Ghassan K. Abou-Alfa 
Section of Gastrointestinal Cancer, Memorial Sloan-Kettering Cancer Center, New York, USA

Status of HCC in China
Shuki Qin 
Chair of Chinese Society of Clinical Oncology (CSCO); Deputy director of People’s Liberation Army (PLA) 81 Hospital (Nanjing, China); Director of Cancer Center of Chinese PLA

Status of HCC in Japan 
Masafumi Ikeda 
Division of Hepatobiliary and Pancreatic Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan

Status of HCC in Korea 
HooGuen Chun 
Comprehensive Cancer Institute, Catholic University of Korea, 222 Banpo-daero, Seocho-gu, Seoul, Korea

Status of HCC in Egypt
Ashraf Abdelaziz
Section of Gastroeneterology, Cairo University, Egypt

Status of HCC in India  
G. S. Bhattacharyya
Dept. of Medical Oncology, FORTIS Hospitals, Anandapur, EM Byepass, Kolkata, India, AMRI,Kolkata, India

Status of HCC in USA
Andrew Zhu 
Liver Cancer Research,Massachusetts General Hospital Cancer Center, Boston, MA, USA

Status of HCC in Europe 
Tim Meyer 
UCL Cancer Institute, University College London, London, United Kingdom